During the past decade, Pontificia Universidad Católica de Chile conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 12 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 7 clinical trials were completed. i.e. 19.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pontificia Universidad Católica de Chile" #1 sponsor was "Pontificia Universidad Catolica de Chile" with 36 trials, followed by "Merck Sharp & Dohme LLC" with 5 trials sponsored, "Fundación para la Investigación del Hospital Clínico de Valencia" with 3 trials sponsored, "Actelion" with 2 trials sponsored and "Ipsen" with 2 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pontificia Universidad Católica de Chile" #1 collaborator was "Pontificia Universidad Catolica de Chile" with 6 trials as a collaborator, "Comisión Nacional de Investigación Científica y Tecnológica" with 4 trials as a collaborator, "Fondo Nacional de Desarrollo Científico y Tecnológico, Chile" with 4 trials as a collaborator, "Amsterdam UMC, location VUmc" with 3 trials as a collaborator and "Hospital Central del IPS" with 3 trials as a collaborator. Other collaborators include 99 different institutions and companies that were collaborators in the rest 92 trials.

According to Clinical.Site data, the most researched conditions in "Pontificia Universidad Católica de Chile" are "Anesthesia" (5 trials), "Gastric Cancer" (5 trials), "Prostatic Neoplasms" (4 trials), "Septic Shock" (4 trials) and "Surgery" (4 trials). Many other conditions were trialed in "Pontificia Universidad Católica de Chile" in a lesser frequency.

Most popular intervention types in "Pontificia Universidad Católica de Chile" are "Drug" (27 trials), "Other" (11 trials), "Biological" (10 trials), "Device" (10 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Pembrolizumab" (5 trials), "Botulinum toxin type A" (2 trials), "Enzalutamide" (2 trials) and "Lactate guided resuscitation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pontificia Universidad Católica de Chile" are 74 trials for "All" genders and 7 trials for "Male" genders.

Currently, there are 27 active trials in "Pontificia Universidad Católica de Chile". 1 are not yet recruiting, 15 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 43 completed trials in Pontificia Universidad Católica de Chile, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pontificia Universidad Católica de Chile, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 26 trials that are defined as “Not Applicable".

Pontificia Universidad Católica de Chile has several departments that took part in Clinical trials: "Division de Anestesia - Pontificia Universidad Catolica de Chile" - 8 trials, "Puc, Nicu" - 4 trials, "Department of Gastroenterology, Pontificia Universidad Catolica de Chile" - 2 trials